A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color

Exclusion Criteria

• •Subject has any skin pathology or condition that could interfere with the evaluation of the test products or requires the use of interfering topical or systemic therapy.
• •Caucasian/ Non-Hispanic
• •Subject has any condition which, in the investigator's opinion, would make it unsafe for the subject to participate in this research study.
• •Pregnant, lactating, or is planning to become pregnant during the study.
• •Subject is currently enrolled in an investigational drug or device study.
• •Subject has received an investigational drug or has been treated with an investigational device within 30 days prior to the initiation of treatment (baseline).
• •Study participant has facial hair that could interfere with the study assessments in the opinion of the investigator.
• •Study participant is unable to communicate or cooperate with the investigator due to language problems, poor mental development, or impaired cerebral function.
• •Subject has known hypersensitivity or previous allergic reaction to any of the active or inactive components of the test articles.
• •Subject has the need or plans to be exposed to artificial tanning devices or excessive sunlight during the trial.